课题基金 / 基金详情

CCR RNAi initiative: High through put validation of siRN

CCR RNAi initiative: High through put validation of siRN
CCR RNAi 计划:siRN 的高通量验证
批准号:
7292891
负责人:
natasha caplen
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

natasha caplen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Gene silencing in mammalian cells through RNA interference (RNAi) has become an invaluable tool for the study of biological processes. RNAi is mediated through the action of small 21 nucleotide duplex RNAs, known as small interfering RNAs (siRNAs), which form part of an endogenous enzyme complex, termed the RNA-induced silencing complex (RISC). More specifically, a single strand of the siRNA duplex is selectively loaded into RISC where it provides stringent guidance for the catalytic cleavage of complementary mRNA transcripts. We are employing RNAi for the exploration of cancer-associated pathways including the validation of anti-cancer targets, the potential identification of new targets, the development of novel model systems, and the elucidation/validation of integral components of cancer related phenotypes. To access large-scale synthetic siRNA resources GSS has developed a research collaboration agreement with Qiagen Inc. To date Qiagen has designed and synthesized siRNAs corresponding to approximately 400 genes. To make full use of these resources have developed a high throughput automated synthetic siRNA-lipid "reverse transfection" protocol in a 96 well plate format (BioRobot 8000, Qiagen Inc.). To date we have assayed the knockdown mediated by 267 siRNAs corresponding to 131 human genes. Over 70% of these siRNAs show a statistically significant decrease in the steady state levels of the expression of the gene under study. We are actively investigating the reasons for why some siRNAs fail to silence. In many cases we suspect that a failure to induce silencing often reflects issues related to the expression of different alternative transcripts of the gene in question and single nucleotide polymorphisms that block cleavage by the siRNA-RISC complex. In a limited number of cases we have also investigated the specificity of the siRNAs. In addition to validation we are now expanding this platform to allow us to further our pharmocogenomic studies through the development of a combinatorial library approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RNAi analysis of the ATP-binding cassette (ABC) family o
RNAi for the identification of Hypoxia responsive genes
CCR RNAi Initiative: Establishment of shRNA RNAi Library Screens
  • 批准号:
    7592800
  • 项目类别:
  • 资助金额:
    $20.95万
  • 财政年份:
    --
  • 负责人:
    natasha caplen
  • 依托单位:
RNAi Analysis of the ATP-binding Cassette (ABC) Family of Proteins
国内基金
海外基金
水稻病毒调控OsMADS1介导的RNAi抗病毒机制研究
  • 批准号:
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2024
  • 负责人:
    闫文凯
  • 依托单位:
暗黑鳃金龟幼虫RNAi通路关键基因的鉴定与作用机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
RNAi介导的抗黄曲条跳甲油菜新种质创制
核交联siRNA胶束用于脑胶质瘤的RNAi/铁死亡联合治疗
  • 批准号:
    52373133
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    郑蒙
  • 依托单位: